Patents by Inventor Jeffery A. McGarvey

Jeffery A. McGarvey has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Use of phyllosphere associated lactic acid bacteria as biocontrol agents to reduce bacterial growth on fresh produce
    Patent number: 10264808
    Abstract: The present invention relates to the use of phyllosphere-associated lactic acid bacteria that demonstrate inhibitory effects on the growth and maintenance of human pathogens, such as Salmonella enterica, on the surface of food products, particularly fresh fruits and vegetables. Particular strains of Enterococcus avium and Lactococcus lactis are described and detailed for their atypical pathogen-inhibiting phenotypes.
    Type: Grant
    Filed: December 13, 2016
    Date of Patent: April 23, 2019
    Assignee: The United States of America, as Represented by the Secretary of Agriculture
    Inventors: Jeffery A. McGarvey, Robert M. Hnasko, Larry H. Stanker, Lisa A. Gorski
  • Bioassay for cell conditioned media
    Patent number: 9868940
    Abstract: Herein is described a novel hybridoma cell line (RMH359) and its use as a cellular bioassay to determine the efficacy of cell conditioned media (CCM) as a supplement used to support cell survival and promote growth in culture. This bioassay is the first to provide a measure of CCM bioactivity in support of hybridoma cells used in the generation and production of monoclonal antibodies.
    Type: Grant
    Filed: September 15, 2015
    Date of Patent: January 16, 2018
    Assignee: The United States of America, as represented by The Secretary of Agriculture
    Inventors: Robert M. Hnasko, Larry H. Stanker, Jeffery A. McGarvey, Alice V. Lin
  • USE OF PHYLLOSPHERE ASSOCIATED LACTIC ACID BACTERIA AS BIOCONTROL AGENTS TO REDUCE BACTERIAL GROWTH ON FRESH PRODUCE
    Publication number: 20170181456
    Abstract: The present invention relates to the use of phyllosphere-associated lactic acid bacteria that demonstrate inhibitory effects on the growth and maintenance of human pathogens, such as Salmonella enterica, on the surface of food products, particularly fresh fruits and vegetables. Particular strains of Enterococcus avium and Lactococcus lactis are described and detailed for their atypical pathogen-inhibiting phenotypes.
    Type: Application
    Filed: December 13, 2016
    Publication date: June 29, 2017
    Inventors: Jeffery A. McGarvey, Robert M. Hnasko, Larry H. Stanker, Lisa A. Gorski
  • Bioassay for Cell Conditioned Media
    Publication number: 20160076002
    Abstract: Herein is described a novel hybridoma cell line (RMH359) and its use as a cellular bioassay to determine the efficacy of cell conditioned media (CCM) as a supplement used to support cell survival and promote growth in culture. This bioassay is the first to provide a measure of CCM bioactivity in support of hybridoma cells used in the generation and production of monoclonal antibodies.
    Type: Application
    Filed: September 15, 2015
    Publication date: March 17, 2016
    Inventors: Robert M. Hnasko, Larry H. Stanker, Jeffery A. McGarvey, Alice V. Lin
  • High-affinity monoclonal antibodies for botulinum toxin type B
    Patent number: 9145455
    Abstract: High affinity antibodies for binding epitopes of BoNT/B and hybridomas that produce such antibodies are described. The antibodies may be used in a kit for detecting BoNT/B in a sample.
    Type: Grant
    Filed: October 20, 2014
    Date of Patent: September 29, 2015
    Assignee: The United States of America, as represented by The Secretary of Agriculture
    Inventors: Larry H. Stanker, Miles C. Scotcher, Luisa W. Cheng, Robert M. Hnasko, Jeffery A. McGarvey
  • HIGH-AFFINITY MONOCLONAL ANTIBODIES FOR BOTULINUM TOXIN TYPE B
    Publication number: 20150152168
    Abstract: High affinity antibodies for binding epitopes of BoNT/B and hybridomas that produce such antibodies are described. The antibodies may be used in a kit for detecting BoNT/B in a sample.
    Type: Application
    Filed: October 20, 2014
    Publication date: June 4, 2015
    Inventors: Larry H. Stanker, Miles C. Scotcher, Luisa W. Cheng, Robert M. Hnasko, Jeffery A. McGarvey
  • High-affinity monoclonal antibodies for botulinum toxin type B
    Patent number: 8900824
    Abstract: High affinity antibodies for binding epitopes of BoNT/B and hybridomas that produce such antibodies are described. The antibodies may be used in a kit for detecting BoNT/B in a sample.
    Type: Grant
    Filed: September 23, 2011
    Date of Patent: December 2, 2014
    Assignee: The United States of America, as represented by the Secretary of Agriculture
    Inventors: Larry H. Stanker, Miles C. Scotcher, Luisa W. Cheng, Robert M. Hnasko, Jeffery A. McGarvey